Is It Safe to Get CAR-T Therapy in China? A Checklist Before You Travel

The honest answer is: it depends on which hospital, which product, and whether anyone has planned your aftercare — not on the country alone. Here is what to actually check.

1. Is the product actually approved, for your indication?

China's National Medical Products Administration (NMPA) has approved at least nine CAR-T products as of 2026, each for specific, defined indications. Ask any provider to name the exact product and confirm, in writing, that your diagnosis matches its approved indication — and to tell you plainly if what's being proposed is instead off-label use or a clinical trial, which carry a different risk and evidence profile.

2. Is the hospital equipped for the complications, not just the infusion?

Cytokine release syndrome and neurological side effects require rapid access to intensive care in some cases. Ask whether the treating hospital has an onsite or immediately available ICU experienced in managing CAR-T complications, not just an infusion suite.

3. Is there a written plan for when you go home?

A widely cited 2026 health-policy critique of international CAR-T travel made this the central safety issue: patients often return home without records their local team can use, a reliable contact at the treating hospital, or a financed plan for complications. Before you commit, ask for:

• A written shared-care agreement naming who does what at home, and at what intervals (commonly day 30, day 180, and year one or beyond).
• A treatment passport with the exact product, batch number, medicines given, and your monitoring schedule, in a format your home hospital can use immediately.
• A clear answer on who pays for complications after you return home, and whether that's covered in your quotation.

4. Is the pricing itemized?

A single bundled number that can't be broken down into therapy, hospitalization, potential ICU care, and follow-up is a reason for caution, regardless of which country or hospital is offering it. See our cost comparison guide for what a proper quotation includes.

5. Will anyone tell you "no"?

A provider that has never told a prospective patient they don't qualify is a provider you should question. CAR-T therapy is not appropriate for everyone, and a credible medical review process will sometimes conclude that it isn't right for you — and should say so clearly, in writing, before you travel.